BRIEF-Navidea says it completed type A meeting with FDA on lymphoseek NDA

Oct 10 (Reuters) - Navidea Biopharmaceuticals Inc :

* Completed type a meeting with FDA on lymphoseek NDA

* Received clarifying guidance from agency in regard to CGMP issues noted in

FDA's response letter

* Continues to believe this process will not entail a re-review of the full


* Believes that majority of third-party manufacturing facilities requirements

to address deficiencies have been completed

* Source text:* Further company coverage ((Bangalore Newsroom; +1 646 223 8780))